The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reducing regorafenib toxicity by combining with dual JAK-HDAC inhibitor in colorectal cancer.
 
Prachi Bajpai
No Relationships to Disclose
 
Sumit Agarwal
No Relationships to Disclose
 
Darshan S Chandrashekar
No Relationships to Disclose
 
Amr Elkholy
No Relationships to Disclose
 
Hyung Gyoon Kim
No Relationships to Disclose
 
Farrukh Afaq
No Relationships to Disclose
 
Santosh K Singh
No Relationships to Disclose
 
Abigail Shelton
No Relationships to Disclose
 
Ryan Bash
No Relationships to Disclose
 
Rajesh Singh
No Relationships to Disclose
 
Sooryanarayana Varambally
No Relationships to Disclose
 
C Ryan Miller
No Relationships to Disclose
 
Ravi Kumar Paluri
Honoraria - Amgen; Ipsen
Speakers' Bureau - Ipsen
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Aprea therapeutics; Blueprint Medicines; Cardiff Oncology; Daiichi Sankyo; Global Blood Therapeutics; Guardant Health; Halozyme; Moderna Therapeutics; Regeneron
Consulting or Advisory Role - AstraZeneca; Bayer; Taiho Pharmaceutical
Speakers' Bureau - AstraZeneca; Pfizer
 
Sameer Al Diffalha
No Relationships to Disclose
 
Upender Manne
No Relationships to Disclose